SCHEMBL7989202

SCHEMBL7989202

CNC(=O)[C@H](Cc1ccccc1)NC(=O)C1(CS)CCCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 18/20 1.00
MMP2 P08253 1/20 0.58
MMP3 P08254 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982516 1.00 MMP1 (1.00) MMP1MMP2MMP3
SCHEMBL7985530 0.85 MMP1 (1.00) MMP1
SCHEMBL7982690 0.85 MMP1 (0.83) MMP1
SCHEMBL7066076 0.84 MMP1 (0.80) MMP1
SCHEMBL7066075 0.84 MMP1 (0.80) MMP1
SCHEMBL7986383 0.84 MMP1 (1.00) MMP1
SCHEMBL7985520 0.84 MMP1 (0.75) MMP1
SCHEMBL7064472 0.83 MMP1 (1.00) MMP1
SCHEMBL7064613 0.83 MMP1 (1.00) MMP1
SCHEMBL3706048 0.82 MMP1 (0.70) MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201133-B1 FOR INHIBITING MATRIX-DEGRADING METALLOPROTEINASES IN MAMMALS, TREATING TNF ALPHA AND MATRIX METALLOPROTEINASE DEPENDENT DISEASES OR CONDITIONS, CANCER NOVARTIS AG (CH) 2001-03-13 US disclosed